Newsfeeds Archive - Spark Newswire

3 minute read

Aprea Therapeutics Announces Presentations On Its Next Generation WEE1 Inhibitor, APR-1051, And A Novel Macrocyclic ATR Inhibitor, ATRN-119, At AACR Annual Meeting 2024

April 10, 12:02 PM

Pre-clinical findings underscore the potential of APR-1051, a next-generation WEE1 kinase inhibitor, to be a well-tolerated and effective treatment for Cyclin E-overexpressing cancers IND for APR-1051 has been

APRE

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

April 4, 8:09 AM

Gainers Tevogen Bio Holdings (NASDAQ:TVGN) stock rose 85.5% to $4.86 during Thursday’s pre-market session. The market value of…

ACHL

1 minute read

Aprea Therapeutics Announces Submission Of IND Application For APR-1051, A Next Generation WEE1 Kinase Inhibitor

By Benzinga Newsdesk

February 6, 9:03 AM

Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that it has submitted an

APRE

3 minute read

Aprea Therapeutics Provided A Corporate Update Highlighting Recent Developments And Plans For Advancement Of Its Pipeline Of DNA Damage Response Anti-Cancer Agents In 2024

By Benzinga Newsdesk

January 4, 5:12 PM

Update on Phase 1/2a Ongoing Trial of ATR Program, ATRN-119Enrollment of patients continues in the dose escalation portion of the Phase 1/2a clinical trial (study AR-276-01) evaluating ATRN-119 in patients with advanced

APRE

2 minute read

News

A Look Into Healthcare Sector Value Stocks

By Benzinga Insights

October 30, 10:43 AM

What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices…

APRE

3 minute read

Aprea Unveils Initial Clinical Data On ATRi, ATRN-119, And Pre-Clinical Data On WEE1i, ATRN-1051, At AACR-NCI-EORTC International Conference Supporting Highly Differentiated Synthetic Lethality Portfolio

By Benzinga Newsdesk

October 16, 8:45 AM

APRE

1 minute read

News

5 Value Stocks To Watch In The Healthcare Sector

By Benzinga Insights

September 25, 10:44 AM

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of…

AGRX

1 minute read

News

5 Value Stocks To Watch In The Healthcare Sector

By Benzinga Insights

September 4, 10:44 AM

Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies…

APRE

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

July 18, 5:32 PM

Gainers Etao International Co (NASDAQ:ETAO) shares rose 10.3% to $0.48 during Tuesday’s after-market session. The market value of…

AMRN

2 minute read

Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying

By Lisa Levin

June 9, 7:30 AM

The Dow Jones closed higher by over 160 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

APRE